@author-1788515151757110
启明创投致力于成为中国优秀技术创业者们的首选投资机构
This isn't just a successful investment case — it more profoundly reveals the path by which China's pharmaceutical innovation is being revalued.
China will become the world's "token factory" in the future. In the past, Made in China meant manufacturing. Now, it's AI Made in China.
Staying with you through milestone moments at Qiming Venture Partners' portfolio companies
In this 8–10 week internship program, you'll have the opportunity to work alongside some of the most innovative founders in biotech, health tech, and AI-powered healthcare — with dedicated growth opportunities built just for you.
The real explosion of consumer-facing AI applications may require a massive shift in business models to make it happen.
Staying with you to mark the milestone moments of Qiming Venture Partners' portfolio companies
The "ChinaVenture Ranking" has been published for 20 consecutive years, and is known throughout the industry for its professionalism, authority, and rigor. It is regarded as a bellwether for China's equity investment industry and serves as an important reference for capital commitments from many large institutional LPs.
We're not afraid of failure at all, but we want to move fast and generate a lot of original, self-driven solutions and ideas.
Staying with you to mark the milestone moments of Qiming Venture Partners' portfolio companies.
We sincerely invite top scientists to visit the S2SChina website and submit proposals, embarking on an accelerated journey from the lab to entrepreneurship.
